The loss of enzymes responsible for BCAAs utilization, Bcat1 and Bcat2, impairs NSCLC tumor formation, although these enzymes are not essential for PDAC tumor formation (Li et al., 2020). The gene discussed is BCAT1; the disease is neoplasm.